Analysis of Human Movement With Assistive Devices

Summary

The purpose of this research is to evaluate how people move about in different settings with different assistive devices or components, and to understand how people interact with different assistive technologies. Individuals that have limb weakness, limb paralysis, limb loss, and movement disorders are often provided assistive devices such as prostheses and orthoses to assist with mobility or use assistive technologies for purposes such as to regain muscle strength or retrain movements. It is important to understand the impact of these different assistive technologies on human movement for technology improvement and in preparation for commercialization.

Because this research focuses on evaluating how different people move about in different settings with different assistive devices/components, there are different activities that may take place. These activities have been classified as (1) Movement Analysis in the Laboratory, (2) Movement Analysis Outside the Laboratory, (3) Usability Testing, and (4) Focus Groups. Each participant may or may not complete the same activities as the other participants. Each participant may or may not complete all of the activities. Participants may complete the activities more than once.

Conditions

• Limb Loss
• Limb Weakness
• Limb Paralysis
• Movement Disorders

Interventions

DEVICE

Assist-Knee

Investigational prosthetic knee-ankle device

DEVICE

Prosthetic Knee

Commercially available prosthetic knee devices

DEVICE

Prosthetic Ankle

Commercially available prosthetic ankle devices

DEVICE

Prosthetic Foot

Commercially available prosthetic foot devices

DEVICE

Ankle-Foot Orthosis

Commercially available ankle-foot orthosis devices

Sponsors & Collaborators

• Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

  collaborator NIH

• Orthocare Innovations, LLC

  lead INDUSTRY

Principal Investigators

• Adam Arabian, PhD · Orthocare Innovations, LLC

Study Design

Allocation

NON_RANDOMIZED

Purpose

OTHER

Masking

NONE

Model

SEQUENTIAL

Eligibility

Min Age

18 Years

Max Age

90 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2022-11-28

Primary Completion

2024-11-28

Completion

2024-11-28

FDA Device

Yes

Countries

• United States

Study Locations